---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-076234"
form_type: "8-K"
ticker: "KZR"
cik: "0001645666"
company_name: "Kezar Life Sciences, Inc."
filed_at: "2024-06-21T23:59:59+00:00"
generated_at: "2026-06-01T02:51:56.047904+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Kezar Life Sciences stockholders reject Say-on-Pay, approve reverse split authorization

## Summary
- Say-on-Pay advisory vote failed: 27.2M against vs 19.8M for.
- Reverse stock split authorized (ratio 1:2 to 1:20) at Board's discretion.
- Directors Christopher Kirk and John Fowler elected with >33M votes each.
- KPMG ratified as independent auditor for FY2024 with overwhelming support.
- Company will hold annual Say-on-Pay votes until 2030 after advisory vote.

## SEC filing metadata
- accession: 0000950170-24-076234
- form_type: 8-K
- ticker: KZR
- cik: 0001645666
- company_name: Kezar Life Sciences, Inc.
- filed_at: 2024-06-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645666/000095017024076234/0000950170-24-076234-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645666/000095017024076234/kzr-20240618.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-076234
- JSON: https://secwatch.observer/filing/0000950170-24-076234.json
- Plain text: https://secwatch.observer/filing/0000950170-24-076234.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.